HOME
Investor Relations
Press Release (2010)
2010/02/01
Financial Results for the Third Quarter of Fiscal Year 2009
2010/01/26
A Novel Anti-viral Drug for Influenza,"RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion" Launch
2010/01/25
Shionogi Supports Relief Efforts for Haiti Earthquake Victims
2010/01/20
Shionogi Receives Marketing and Manufacturing Approval of an Antidepressant Drug,"Cymbalta ®Capsules 20mg and 30mg"
2010/01/13
Shionogi Receives Marketing and Manufacturing Approval of a Novel Anti-viral Drug for Influenza, "RAPIACTA 300mg Bag for Intravenous Drip Infusion" and "RAPIACTA 150mg Vial for Intravenous Drip Infusion"
2010/01/12
SCIELE PHARMA, INC., A SHIONOGI GROUP COMPANY, ANNOUNCES NAME CHANGE
To view these files you must have the Adobe Reader installed on your system. Adobe Reader is availabe for free from the Adobe website. To download and install the software please click on the button.
Press Release(2010)
Press Release Backnumber
Second Medium-Term Business Plan
Financial Highlights
Financial Data
Annual Report
IR Calendar
Conferences and Presentaions
Pipeline
General Meeting of Shareholders
Search
Japanese
sitemap
